中文｜English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R
Volume 40 Issue 3
Mar.  2024
Turn off MathJax
Article Contents
Article Navigation >  Journal of Clinical Hepatology  > 2024  >  40(3): 562-567

Influencing factors for the prognosis of patients with drug-induced liver injury and establishment of a nomogram model

DOI: 10.12449/JCH240320
  • 1a.

    Department of Infectious Diseases，Heilongjiang Provincial Hospital Affiliated to Harbin Institute of Technology，Harbin 150036，China

  • 1b.

    Department of Pharmacy，Heilongjiang Provincial Hospital Affiliated to Harbin Institute of Technology，Harbin 150036，China

  • 2.

    School of Big Health，Guizhou Medical University，Guiyang 550025，China

Research funding:

Scientific Research Project of Health Commission of Heilongjiang Province (20210303080081);

Heilongjiang Postdoctoral Scientific Research Development Fund (LBH-Q20056)

More Information
  • Corresponding author: HU Xiaoli， huxiaoli1976@163.com （ORCID： 0000-0002-4615-1299）
  • Received Date: 2023-05-30
  • Accepted Date: 2023-07-12
  • Published Date: 2024-03-20
    Abstract
  •   Objective  To investigate the influencing factors for the clinical outcome of patients with drug-induced liver injury （DILI）， and to establish a nomogram prediction model for validation.  Methods  A retrospective analysis was performed for the general information and laboratory data of 188 patients with DILI who were admitted to Heilongjiang Provincial Hospital Affiliated to Harbin Institute of Technology from January 2017 to December 2022， and according to their clinical outcome， they were divided into good outcome group with 146 patients and poor outcome group with 42 patients. The independent-samples t test was used for comparison of normally distributed continuous data between two groups， and the Mann-Whitney U test was used for comparison of non-normally distributed continuous data between two groups； the chi-square test was used for comparison of categorical data between two groups. Univariate and multivariate Logistic regression analyses were used to investigate the independent influencing factors for the clinical outcome of DILI patients. R Studio 4.1.2 software was used to establish a nomogram model， and calibration curve， receiver operating characteristic （ROC） curve， and decision curve analysis （DCA） were used to perform internal validation.  Results  The univariate Logistic regression analysis showed that liver biopsy for the diagnosis of DILI， platelet count， cholinesterase， albumin， prothrombin time activity， IgM， and IgG were associated with adverse outcomes in patients with DILI. The multivariate Logistic regression analysis showed that liver biopsy for the diagnosis of DILI （odds ratio ［OR］=0.072， 95% confidence interval ［CI］： 0.022‍ ‍—‍ ‍0.213， P<0.001）， clinical classification （OR=0.463， 95%CI： 0.213‍ ‍—‍ ‍0.926， P=0.039）， alanine aminotransferase （OR=0.999， 95%CI： 0.998‍ ‍—‍ ‍1.000， P=0.025）， prothrombin time activity （OR=0.973， 95%CI： 0.952‍ ‍—‍ ‍0.993， P=0.011）， and IgM （OR=1.456， 95%CI： 1.082‍ ‍—‍ ‍2.021， P=0.015） were independent influencing factors for clinical outcome in patients with DILI. The nomogram prediction model was established， and after validation， the calibration curve was close to the reference curve. The area under the ROC curve was 0.829， and the DCA curve showed that the model had good net clinical benefit.  Conclusion  The nomogram prediction model established in this study has good clinical calibration， discriminative ability， and application value in evaluating the clinical outcome of patients with DILI.

     

    • FullText(HTML)
  • loading
    • References(11)
  • [1]
    KAPLOWITZ N. Idiosyncratic drug hepatotoxicity[J]. Nat Rev Drug Discov, 2005, 4( 6): 489- 499. DOI: 10.1038/nrd1750.
    [2]
    NAVARRO VJ, SENIOR JR. Drug-related hepatotoxicity[J]. N Engl J Med, 2006, 354( 7): 731- 739. DOI: 10.1056/NEJMra052270.
    [3]
    CHALASANI NP, HAYASHI PH, BONKOVSKY HL, et al. ACG Clinical Guideline: The diagnosis and management of idiosyncratic drug-induced liver injury[J]. Am J Gastroenterol, 2014, 109( 7): 950- 966. DOI: 10.1038/ajg.2014.131.
    [4]
    Chinese Medical Association, Chinese Medical Journals Publishing House, Chinese Society of Gastroenterology, et al. Guideline for primary care of drug-induced liver injury(2019)[J]. Chin J Gen Pract, 2020, 19( 10): 868- 875. DOI: 10.3760/cma.j.cn114798-20200812-00900.

    中华医学会, 中华医学会杂志社, 中华医学会消化病学分会, 等. 药物性肝损伤基层诊疗指南(2019年)[J]. 中华全科医师杂志, 2020, 19( 10): 868- 875. DOI: 10.3760/cma.j.cn114798-20200812-00900.
    [5]
    BALACHANDRAN VP, GONEN M, SMITH JJ, et al. Nomograms in oncology: More than meets the eye[J]. Lancet Oncol, 2015, 16( 4): e173- e180. DOI: 10.1016/S1470-2045(14)71116-7.
    [6]
    PARK SY. Nomogram: An analogue tool to deliver digital knowledge[J]. J Thorac Cardiovasc Surg, 2018, 155( 4): 1793. DOI: 10.1016/j.jtcvs.2017.12.107.
    [7]
    IASONOS A, SCHRAG D, RAJ GV, et al. How to build and interpret a nomogram for cancer prognosis[J]. J Clin Oncol, 2008, 26( 8): 1364- 1370. DOI: 10.1200/JCO.2007.12.9791.
    [8]
    CHEN S, YANG CQ. Drug-induced liver injury: Advances and confusions in treatment[J]. J Clin Hepatol, 2021, 37( 11): 2505- 2509. DOI: 10.3969/j.issn.1001-5256.2021.11.001.

    陈帅, 杨长青. 药物性肝损伤治疗的进展与困惑[J]. 临床肝胆病杂志, 2021, 37( 11): 2505- 2509. DOI: 10.3969/j.issn.1001-5256.2021.11.001.
    [9]
    European Association for the Study of the Liver. EASL Clinical Practice Guidelines: Drug-induced liver injury[J]. J Hepatol, 2019, 70( 6): 1222- 1261. DOI: 10.1016/j.jhep.2019.02.014.
    [10]
    BONKOVSKY HL, KLEINER DE, GU JZ, et al. Clinical presentations and outcomes of bile duct loss caused by drugs and herbal and dietary supplements[J]. Hepatology, 2017, 65( 4): 1267- 1277. DOI: 10.1002/hep.28967.
    [11]
    JEONG R, LEE YS, SOHN C, et al. Model for end-stage liver disease score as a predictor of short-term outcome in patients with drug-induced liver injury[J]. Scand J Gastroenterol, 2015, 50( 4): 439- 446. DOI: 10.3109/00365521.2014.958094.
    • Relative Articles
    • Supplements(0)
    • Cited By
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(4)  / Tables(3)

    Get Citation
    PDF
    XML

    Article Metrics

    Article views (274) PDF downloads(52) Cited by()
    Proportional views
    Related
        

    The first journal specializing in hepatobiliary and pancreatic diseases in China

    Supervisor：Ministry of Education of the People's Republic of China

    Sponsor：Jilin University

    Academic Support: Chinese Society of Hepatology，Chinese Medical Association

    Address: 461 Xinjiang Road, Changchun

    Submit：0431-88782044

    Peer review：0431-88783542

    Email：lcgdb@vip.163.com

    About Journal

    Submission Guideline

    Journal Online

    Hepatobiliary College

    Guidelines

    YesterdayIP[]YesterdayPV[]TodayIP[]TodayPV[]Online[]

    Website Design © 2020 Editorial Board of Journal of Clinical Hepatology 吉ICP备10000617号-1 Supported by: Beijing Renhe Information Technology Co. Ltd  

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return